AACR 2022: New 'killer' immunotherapy shows early promise in range of solid tumours 08 Apr 2022 A new type of immunotherapy making use of the immune system’s ‘natural killer cells’ could offer potential against a range of cancers that can evade current treatments, early results from a phase I trial suggest. Find out more Show/Hide
Recreating a signalling process in the test tube provides clues to bowel cancer 19 Aug 2021 Scientists have, for the first time, recreated an assembly of proteins known as the β-catenin destruction complex in the test tube. This is a long-awaited step in cancer research, as mutations in this destruction complex are found in a large percentage of bowel and other cancers. Find out more Show/Hide
Scientists make ‘long-range weather forecasts’ of bowel cancer’s drug resistance 20 May 2021 Scientists can use genetic ‘weather forecasting’ to predict how long it will take for bowel cancer to evolve resistance to a drug before a patient has even started treatment, a new study has shown. Find out more Show/Hide
AACR Virtual Annual Meeting 2020: Personalised cancer vaccine shows promise in early trial 22 Jun 2020